KALARIS THERAPEUTICS INCKLRS
ASignal's systematic analysis rates KLRS as Bearish.
Reflects the latest available analysis · analyzed Oct 25, 2026
The case on KLRS
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong financial health score (0.9)
- Low debt-to-equity ratio (0.02x)
- High current and quick ratios indicating strong liquidity
- Large cash position ($93.54M) relative to market cap
- Negative MACD and declining price momentum
- Negative return on equity (-79.91%) and return on assets (-31.03%)
- Negative operating and free cash flow
- No recent news coverage or retail sentiment data
See the full verdict on KLRS
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes KLRS
Most investors never get a second opinion, let alone several. ASignal runs KLRS past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.